First patients to receive experimental Cancer-Fighting drug
Disease control
Recruiting now
This is the first study in people to test a new drug called CBI-1214, which is designed to help the body's own immune cells attack cancer. It is for adults with advanced or metastatic colorectal cancer that has continued to grow despite prior standard treatments. The main goals a…
Phase: PHASE1 • Sponsor: Cartography Biosciences • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC